Figure 9
Drug prediction for SKCM patients. (A–H) IC50 prediction for Axitinib, Bosutinib, Cisplatin, Dasatinib, Gefitinib, Nilotinib, Sunitinib, and Imatinib at distinct risk groups.
Figure 9 | Scientific Reports
Drug prediction for SKCM patients. (A–H) IC50 prediction for Axitinib, Bosutinib, Cisplatin, Dasatinib, Gefitinib, Nilotinib, Sunitinib, and Imatinib at distinct risk groups.
